Literature DB >> 15853750

Biological properties of baicalein in cardiovascular system.

Yu Huang1, Suk-Ying Tsang, Xiaoqiang Yao, Zhen-Yu Chen.   

Abstract

The dried roots of Scutellaria baicalensis (S. baicalensis) Georgi (common name: Huangqin in China) have been widely employed for many centuries in traditional Chinese herbal medicine as popular antibacterial and antiviral agents. They are effective against staphylococci, cholera, dysentery, pneumococci and influenza virus. Baicalein, one of the major flavonoids contained in the dried roots, possesses a multitude of pharmacological activities. The glycoside of baicalein, baicalin is a potent anti-inflammatory and anti-tumor agent. This review describes the biological properties of baicalein (Table 1), which are associated with the prevention and treatment of cardiovascular diseases. Baicalein is a potent free radical scavenger and xanthine oxidase inhibitor, thus improving endothelial function and conferring cardiovascular protective actions against oxidative stress-induced cell injury. Baicalein lowers blood pressure in renin-dependent hypertension and the in vivo hypotensive effect may be partly attributed to its inhibition of lipoxygenase, resulting in reduced biosynthesis and release of arachidonic acid-derived vasoconstrictor products. On the other hand, baicalein enhances vasoconstricting sensitivity to receptor-dependent agonists such as noradrenaline, phenylephrine, serotonin, U46619 and vasopressin in isolated rat arteries. The in vitro effect is likely caused by inhibition of an endothelial nitric oxide-dependent mechanism. The anti-thrombotic, anti-proliferative and anti-mitogenic effects of the roots of S. baicalensis and baicalein are also reported. Baicalein inhibits thrombin-induced production of plasminogen activator inhibitor-1, and interleukin-1beta- and tumor necrosis factor-alpha-induced adhesion molecule expression in cultured human umbilical vein endothelial cells. The pharmacological findings have highlighted the therapeutic potentials of using plant-derived baicalein and its analogs for the treatment of arteriosclerosis and hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853750     DOI: 10.2174/1568006043586206

Source DB:  PubMed          Journal:  Curr Drug Targets Cardiovasc Haematol Disord        ISSN: 1568-0061


  59 in total

1.  Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Yury Maksimchyk; Tamara M Kuchmerovska; Jerry L Nadler; Irina G Obrosova
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330

Review 2.  Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.

Authors:  Yanwei Li; Jinying Zhao; Christian Hölscher
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

3.  In vitro evidence of baicalein's inhibition of the metabolism of zidovudine (AZT).

Authors:  Yu-Cun Wang; Hai-Yan Yang; Ling-Ting Kong; Feng-Xia Yu
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

4.  Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.

Authors:  D Altavilla; L Minutoli; F Polito; N Irrera; S Arena; C Magno; M Rinaldi; B P Burnett; F Squadrito; A Bitto
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

5.  Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway.

Authors:  Yu-min Liu; Xiong Wang; Ahmed Nawaz; Zhao-hong Kong; Yan Hong; Chang-hua Wang; Jun-jian Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

6.  Catechol-O-Methyltransferase and UDP-Glucuronosyltransferases in the Metabolism of Baicalein in Different Species.

Authors:  Ruiya Zhang; Yonglei Cui; Yan Wang; Xiangge Tian; Lu Zheng; HaiJian Cong; Bin Wu; Xiaokui Huo; Chao Wang; BaoJing Zhang; Xiaobo Wang; Zhonghui Yu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

7.  A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.

Authors:  Letteria Minutoli; Herbert Marini; Mariagrazia Rinaldi; Alessandra Bitto; Natasha Irrera; Gabriele Pizzino; Giovanni Pallio; Margherita Calò; Elena Bianca Adamo; Vincenzo Trichilo; Monica Interdonato; Federica Galfo; Francesco Squadrito; Domenica Altavilla
Journal:  Neuromolecular Med       Date:  2015-04-19       Impact factor: 3.843

8.  Hesperedin promotes MyoD-induced myogenic differentiation in vitro and in vivo.

Authors:  Hana Jeong; Joo Yeon Lee; Eun Jung Jang; Eun Hye Lee; Myung Ae Bae; Jeong-Ho Hong; Eun Sook Hwang
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

9.  The lipoxygenase inhibitor, baicalein, modulates cell adhesion and migration by up-regulation of integrins and vinculin in rat heart endothelial cells.

Authors:  Y-C S Hsieh; S-J Hsieh; Y-S Chang; C-M Hsueh; S-L Hsu
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

10.  The safety of flavocoxid, a medical food, in the dietary management of knee osteoarthritis.

Authors:  Sarah L Morgan; Joseph E Baggott; Larry Moreland; Renee Desmond; Angela C Kendrach
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.